Increasing confidence in biosimilar medicines
/Overview
Slow uptake of biosimilar medicines is putting increasing pressure on the Australian healthcare system. To increase confidence and awareness among healthcare professionals and consumers, we implemented a multi-channel, targeted social media strategy. By delivering educational and engaging content, we aimed to increase uptake of biosimilars and generate significant cost reductions for the Australian healthcare system.
/Challenge
Low awareness and understanding of biosimilars among consumers and lack of confidence among healthcare professionals.
/Solution
Since 2019, Cube has implemented a consistent and engaging targeted social media program across three channels. The goal was to help drive awareness and education of biosimilars among target HCPs and consumers, as well as drive traffic to an online educational website (Biosimilar Hub – www.biosimilarhub.com.au), which housed further resources and information.
Impact
With minimal paid spend since the launch of the @BiosimilarsAu social media channels in 2019, Cube has helped raise over 1,300 collective followers. In the first half of 2020 alone Cube generated:
Significant social media engagement
Driven over 800,000 impressions and more than 8,300 clicks on content. Delivered an average engagement rate of 6.58% on LinkedIn – well above industry average.
Successful traffic conversion
1,677 click-throughs to online microsite (double 2019 figures).
Increase in followers on key channel
Five times increase in followers on X with an almost 300% increase in click-through rate on content.
TESTIMONIAL
Cube has partnered with Biocelect managing the arrival of a COVID-19 vaccine to Australia and New Zealand. The team has worked attentively and collaboratively with Biocelect and the US team in managing the challenging pandemic and vaccine dynamics as they evolve. They have applied their strategic communication, crisis management and media skills to be pre-emptive and agile in preparing for and managing local media and political commentary. They are responsive, professional, a pleasure to work with and, like Biocelect, hardworking!
We brought Cube in as an external agency to support us with a communications initiative for one of our products in 2019. Now – I don’t know what I would do without them! They are no longer viewed as ‘the agency’, but integral to the Novartis team – as partners and strategic advisors. Now working across multiple portfolios, Cube consistently bring their high-level strategic insight, laser focus for detail, and deep expertise across the entire gamut of communications. I would highly recommend Cube to anyone looking for a nimble yet well-rounded agency partner.
In our dealings with Cube over the past 3 years, we have found the team to be very professional, enthusiastic and helpful. Their high level of honesty and integrity means we have full trust in their recommendations and their approach to meeting our needs. Their strategic thinking and recommended plans are always well-considered. They have done high level strategic work for us and developed detailed plans as well as a new service launch. They have been very responsive to our needs and we would not hesitate to engage them again!
MS Australia engaged Cube for two critically important campaigns in the first half of 2022. Their strategic planning and implementation was first-class, and the very significant results has greatly assisted our advocacy work.
For our landmark MS Nurse Care Report launched in Tasmania, Cube crafted a communications plan focussed on local media which as planned, fanned out to outlets across the country. The coverage was astounding and helped raise vital awareness about the role of the MS Nurse in the patient care journey and the need for more funding.
Cube also expertly project-managed a market research study and national communications plan for our Employment & Workplace Survey, launched on World MS Day. This campaign garnered significant media coverage and spotlighted critical issues around employment and MS.
We cannot thank Cube enough for their friendliness, support and compassion for people living with multiple sclerosis.
Working with Cube has been a remarkable experience. Like BeiGene, they are a small team with big ambitions. Time and again, Cube has proven to be an effective, reliable, and responsible partner. They bring enormous energy, detail and innovation to every project and have helped BeiGene achieve the highest goals and meet the tightest timelines. For every idea, they have a solution ready.
We are delighted to work with Cube, whose professional attitude, deep experience and expertise in health communications put them head and shoulders above the competition. In addition to obtaining fantastic coverage for us, we continue to appreciate the attention to detail at every stage from planning through to showcasing the results of our campaigns. Our media strategy, guided by Cube has hit the mark in a judicious approach and fulfilled our strategic purpose.
The Cube team have extensive experience in strategic communications to create impactful campaigns and events and demonstrate a real understanding of our organisation’s brand, objectives, and a broad range of partners and stakeholders. The team are dedicated to and skilful at crafting compelling narratives, securing high-profile media placements, attending to details and navigating through challenges in complex environments.
Collaborating with Cube has been an immensely positive experience. Cube has demonstrated an excellent understanding of our goals and values, ensuring every aspect of the communications plan aligns with GSK’s mission. Their proactive approach in identifying opportunities and potential challenges has been a key factor in the success of our communications efforts. With meticulously planned execution of media engagements, the team’s professionalism, enthusiasm and creativity have exceeded our expectations, making them an indispensable business partner.
